News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Richman Michael
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
03/01/2023 |
4
| Richman Michael (President & CEO) has filed a Form 4 on NextCure, Inc.
Txns:
| Granted 309,000 options to buy
@ $1.55, valued at
$479k
|
|
06/24/2022 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options to buy
@ $1.82, valued at
$72.8k
|
|
02/02/2022 |
4
| Richman Michael (President & CEO) has filed a Form 4 on NextCure, Inc.
Txns:
| Granted 262,400 options to buy
@ $5.57, valued at
$1.5M
|
|
06/29/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
03/16/2021 |
4
| Richman Michael (President & CEO) has filed a Form 4 on NextCure, Inc.
Txns:
| Granted 300,000 options to buy
@ $12.59, valued at
$3.8M
|
|
06/25/2020 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 40,000 options to buy
@ $3.27, valued at
$130.8k
|
|
03/03/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/28/2020 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 5,431 options to buy
@ $3.23, valued at
$17.5k
Granted 20,000 options to buy
@ $3.23, valued at
$64.6k
|
|
10/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/26/2019 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 3,789 options to buy
@ $4.4, valued at
$16.7k
|
|
04/30/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/29/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
10/29/2018 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 3,829 options to buy
@ $4.36, valued at
$16.7k
|
|
07/26/2018 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 2,837 options to buy
@ $5.92, valued at
$16.8k
|
|
04/26/2018 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 2,665 options to buy
@ $6.43, valued at
$17.1k
|
|
10/27/2017 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
07/27/2017 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC.
Txns:
| Granted 3,288 options to buy
@ $5.64, valued at
$18.5k
|
|
06/20/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/27/2017 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
01/30/2017 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
10/27/2016 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
10/24/2016 |
4
| Richman Michael (Director) has filed a Form 4 on GENVEC INC
Txns:
| Granted 22,500 options to buy
@ $0.38, valued at
$8.6k
|
|
10/04/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/01/2016 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
07/01/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
05/18/2016 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
04/29/2016 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
02/18/2016 |
4
| Richman Michael (Director) has filed a Form 4 on PIERIS PHARMACEUTICALS, INC. |
05/01/2013 |
4
| Richman Michael (Director) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns:
| Granted 5,000 options to buy
@ $1.75, valued at
$8.8k
Granted 17,143 options to buy
@ $1.75, valued at
$30k
|
|
03/05/2012 |
4
| Richman Michael (Director) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns:
| Granted 10,000 options to buy
@ $0.94, valued at
$9.4k
Granted 20,600 options to buy
@ $0.94, valued at
$19.4k
|
|
04/07/2011 |
4
| Richman Michael (Director) has filed a Form 4 on Opexa Therapeutics, Inc.
Txns:
| Granted 10,000 options to buy
@ $1.78, valued at
$17.8k
Granted 10,500 options to buy
@ $1.78, valued at
$18.7k
|
|
05/05/2010 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
08/27/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
07/07/2009 |
4
| Richman Michael (Director) has filed a Form 4 on Cougar Biotechnology, Inc. |
|
|